Fig. 1From: A multipeptide vaccine plus toll-like receptor agonists LPS or polyICLC in combination with incomplete Freund’s adjuvant in melanoma patientsClinical trial design. The schema for the clinical trial is shown in a. The zones for dose escalation of LPS in cohort 1 (A-F) are shown in b. The study combinations are numbered c1 - c12 for cohort 1 and c21-c23 for cohort 2 as shownBack to article page